October 23rd, 2024
We are proud to announce that #Surge, supported by #LallianSe since late 2021, made the cover of #NatureBiotechnology this month with their groundbreaking paper, “Discovery of sparse and reliable omics biomarkers with Stabl”.
You can read the full article in open access here: https://lnkd.in/eEACUhxh
April 2, 2024
We are delighted to announce that #Surge, supported by #LallianSe since the end of 2021 has just conpleted its second fundraising of €7.5M !
For more than two years we have worked closely alongside #Surge leaders on the issues of #fundraising and execution of an attractive and coherent #equitystory as a #SparringPartner. But what is a “Sparring Partner”?
He is above all a #partner. With a tailor-made approach and in a relationship of equals, we support, manage, question, strengthen and explore strategies and their implementation together.
We face challenges together, and celebrate victories together. Congratulations to the whole #Team: Julien Hedou, Valentin Picot, Brice Gaudilliere, Dyani Jones, Franck Verdonk, Benjamin Choisy, Grégoire Bellan.
#finance #investment #startup #innovation #PrecisionMedicine
22 septembre 2022
We are delighted to announce that SurgeCare has just completed its first fundraising of €2.5M and concluded an exclusive licensing agreement with Stanford!
For 9 months LallianSe has been working alongside Surge managers as a “Sparring Partner” on fundraising/equity story issues. “Sparring Partner”: what is it?
Tailored support for the management team in its strategic orientationsSupport also in the management, coordination and animation of governanceAccess to our network of Experts and Entrepreneurs in residence
Congratulations to the whole #Team: Julien Hédou, Brice Gaudilliere, Dyani Jones, Franck Verdonk, Benjamin Choisy, Grégoire Bellan, Valentin Picot !
#equitystory #sparringpartner #privateequity #financement#investment